An Overactive Bladder Online Self-management Program With Embedded Avatars: A Randomized Controlled Trial of Efficacy - 01/03/15
, Ramanakumar Anam b, Chandana Karanam b, Pamela Downey b, Jorge G. Ruiz a, bAbstract |
Objective |
To determine whether an avatar-based, online, self-management program is an effective therapeutic approach for women with overactive bladder (OAB). OAB is a highly prevalent symptom complex that significantly impacts health-related quality of life (HRQOL). Behavioral interventions can produce substantial improvement in symptoms and HRQOL. Online education programs offer patients with OAB an alternative to face-to-face self-management instruction. Evidence suggests that avatars (digital humans) embedded into online programs may help persuade and motivate patients to adopt healthy behaviors.
Methods |
In a 12-week, randomized, controlled trial, women (aged >55 years) with symptoms of OAB for at least 3 months were randomized to 2 versions of a 3-part, online, self-management program. After collecting the baseline metrics, the intervention group viewed a generic avatar coach with a self-avatar peer mentor designed to resemble the participant, and the control group viewed the identical online program with voice only. Participants viewed part 1 at week 1 and parts 2 and 3 at week 6. Participants completed daily bladder diaries throughout the 12-week period and OAB-related outcome measures at weeks 1, 6, and 12.
Results |
Forty-one women completed the study (mean age = 61 years, standard deviation = 6). The analysis of covariance of week-12 outcome measures with the baseline as covariates demonstrated significant improvements in the intervention group in OAB questionnaire HRQOL (P = .02; large effect), 24-hour frequency (P <.001; large effect), night-time urination (P <.001; large effect), urgency (P <.001; large effect), and urge incontinence (P <.001; large effect).
Conclusion |
An avatar-based intervention embedded into an online self-management program improved OAB HRQOL and symptoms in women.
Le texte complet de cet article est disponible en PDF.Plan
| Clinicaltrials.gov identifier: NCT02251054. |
|
| Financial Disclosure: The authors declare that they have no relevant financial interests. |
|
| Funding Support: This study was supported by Pfizer, Inc. 2010 OAB-LUTS Competitive Grants Program and the Miami Geriatric Research Education and Clinical Center, Bruce W. Carter Veterans Affairs Medical Center, Miami, Florida, and the South Florida VA Foundation for Research and Education Inc., Miami, Florida. |
Vol 85 - N° 3
P. 561-567 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
